Source link : https://newshealth.biz/health-news/ms-drug-decision-delayed-levodopa-for-stroke-recovery-boosting-astrocytic-nad/
(MedPage Today) — The FDA extended its decision date for investigational tolebrutinib in non-relapsing, secondary progressive multiple sclerosis (MS) to December 28, Sanofi said. The agency also opted to not approve investigational apitegromab… Source link : https://www.medpagetoday.com/neurology/generalneurology/117608 Author : Publish date : 2025-09-23 18:26:00 Copyright for syndicated content belongs to the linked Source.
The post MS Drug Decision Delayed; Levodopa for Stroke Recovery; Boosting Astrocytic NAD+ first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-23 18:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8